Daylife Select
A point & click tool to create dynamic content portals. Learn More »
There is no pinned content in this Editor's Picks module.
Click here to learn more about content pinning.
Sun Micro (JAVA) is up 6 cents to $8.57 and recent trades include the purchase of 7600 Jan 7.5 calls at $1.40 and another 400 at $1.39. 10,000 Jan10 7.5 calls now traded and the buying coincides with a Reuters headline that Oracle will argue its case... Full Article at SchaeffersResearch.com: Daily Market Blog
Carnival Corporation (CCL: sentiment, chart, options) was bombarded by call speculators on Tuesday, after the cruise guru received a bullish brokerage note at Wedbush Morgan. Full Article at SchaeffersResearch.com: Daily Market Blog
The Amgen Tour of California peloton crosses the Golden Gate Bridge in a heavy rain at the beginning of Stage 2 in San Francisco, California February 16, 2009. View Photo »
Drugs should be prescribed to patients on the basis of need, effectiveness, and safety, not on a corporate giant’s promise of an all-expense paid vacation ... In an egregious violation of the law, Amgen allegedly bribed medical providers and left taxpayers footing the bill for free drug samples.
THOUSAND OAKS, Calif. , Nov. 23 /PRNewswire-FirstCall/ -- Amgen (Nasdaq: AMGN) was honored with two 2009 Scrip Awards, winning for Best Overall Pipeline and for Best New Drug for Nplate® (romiplostim), at a Nov. 18 ceremony in London. Full Article at Freshnews.com
Amgen has exclusively licensed ImmunoGen's maytansinoid Targeted Antibody Payload (TAP) technology to develop anticancer therapeutics to an undisclosed target. Full Article at Scrip News
SAN DIEGO, Calif. , Nov. 23 /PRNewswire-FirstCall/ -- Orexigen® Therapeutics, Inc. Full Article at RedOrbit
The Amgen Tour of California peloton crosses the Golden Gate Bridge in a heavy rain at the beginning of Stage 2 in San Francisco, California February 16, 2009. View Photo »
After watching the FDA advisory meeting for denosumab, I believe Amgen will be lucky to get an osteoporosis indication as a second line treatment for women with a high risk of fractures (the PDUFA date is October 19) ... Amgen was literally pounded by the panel on safety. [Eli Lilly's] Forteo (even thou...
Shares of ImmunoGen (IMGN) moved higher in midday trading Friday, a day after the small biotech licensed its cancer treatment technology to Amgen (AMGN) for $1 million upfront. Full Article at Investor's Business Daily
It's hard to find winners in the nightmarish health care reform bill passed by the House... The bill doesn't address the major complaint of the American consumers – soaring costs. In fact, health insurers already predict skyrocketing premiums next year. Full Article at iStockAnalyst
There are no results for this module. Edit this module to change the search term used to query Wikipedia
The Amgen Tour of California peloton crosses the Golden Gate Bridge in a heavy rain at the beginning of Stage 2 in San Francisco, California February 16, 2009. Today's stage finishes in Santa Cruz before continuing south in the 750-mile, nine-day stage race.
View Photo »The Amgen Tour of California peloton crosses the Golden Gate Bridge in a heavy rain at the beginning of Stage 2 in San Francisco, California February 16, 2009. Today's stage finishes in Santa Cruz before continuing south in the 750-mile, nine-day stage race.
View Photo »Astana cyclist Lance Armstrong races Stage 1 of the Amgen Tour of California cycling race in Santa Rosa, California February 15, 2009. Seven stages remain in the 750-mile, nine-day stage race.
View Photo »OUCH cyclist Floyd Landis races Stage 1 of the Amgen Tour of California cycling race in Santa Rosa February 15, 2009. Seven stages remain in the 750-mile, nine-day stage race.
View Photo »Astana cyclist Lance Armstrong races the prologue of the Amgen Tour of California in Sacramento, California February 14, 2009. Saxo Bank cyclist Fabian Cancellara won the prologue, and is the race leader of the 750-mile (1,207-km), nine-day stage race.
View Photo »Winners of the the Amgen Tour of California prolouge cycling race pose on the award platform in Sacramento, Calif. , on Saturday, Feb. 14, 2009. Left to right are second place winner Levi Leipheimer, first place winner Fabian Cancellara, and third place winner David Zabriskie.
View Photo »A racer crosses the finish line at the Amgen Tour of California prolouge cycling race in Sacramento, Calif. , on Saturday, Feb. 14, 2009.
View Photo »Cyclist Floyd Landis crosses the finish line at the Amgen Tour of California prolouge cycling race in Sacramento, Calif. , on Saturday, Feb. 14, 2009.
View Photo »Cyclist Floyd Landis approaches the finish line at the Amgen Tour of California prolouge cycling race in Sacramento, Calif. , on Saturday, Feb. 14, 2009.
View Photo »Lance Armstrong crosses the finish line at the Amgen Tour of California cycling race prologue in Sacramento, Calif. , on Saturday, Feb. 14, 2009.
View Photo »Lance Armstrong warms up for the Amgen Tour of California prolouge bycycle time trial race in Sacramento, Calif. , on Saturday, Feb. 14, 2009.
View Photo »Saxo Bank rider Frank Schleck of Luxembourg finishes stage 8 of the Amgen Tour of California cycling race in Escondido, California February 22, 2009.
View Photo »Ouch rider Rory Sutherland of Australia finishes stage 8 of the Amgen Tour of California cycling race in Escondido, California February 22, 2009.
View Photo »Astana rider Levi Leipheimer of the U.S. waves to the crowd after finishing stage 8 of the Amgen Tour of California cycling race in Escondido, California February 22, 2009. Leipheimer retained his overall lead in the race.
View Photo »Saxo Bank rider Frank Schleck of Luxembourg finishes stage 8 of the Amgen Tour of California cycling race in Escondido, California February 22, 2009.
View Photo »Liquigas cyclist Vincenzo Nibali races in the time trial of the Amgen Tour of California in Solvang, California February 20, 2009.
View Photo »A child holds up a sign of support for Astana cyclist Lance Armstrong during the time trial of the Amgen Tour of California in Solvang, California February 20, 2009.
View Photo »Astana cyclist Levi Leipheimer wipes his face after the time trial of the Amgen Tour of California in Solvang, California February 20, 2009.
View Photo »Astana cyclist Christopher Horner races in the time trial of the Amgen Tour of California in Solvang, California February 20, 2009.
View Photo »Astana cyclist Christopher Horner races in the time trial of the Amgen Tour of California in Solvang, California February 20, 2009.
View Photo »Liquigas cyclist Vincenzo Nibali races in the time trial of the Amgen Tour of California in Solvang, California February 20, 2009.
View Photo »Astana cyclist Lance Armstrong races in the time trial of the Amgen Tour of California in Solvang, California February 20, 2009.
View Photo »Team Columbia-High Road cyclist Michael Rogers races in the time trial of the Amgen Tour of California in Solvang, California February 20, 2009.
View Photo »Astana cyclist Lance Armstrong races in the time trial of the Amgen Tour of California in Solvang, California February 20, 2009.
View Photo »Astana cyclist Lance Armstrong races in the time trial of the Amgen Tour of California in Solvang, California February 20, 2009.
View Photo »The Amgen Tour of California peloton crosses the Golden Gate Bridge in a heavy rain at the beginning of Stage 2 in San Francisco, California February 16, 2009. Today's stage finishes in Santa Cruz before continuing south in the 750-mile, nine-day stage race.
View Photo »Drugs should be prescribed to patients on the basis of need, effectiveness, and safety, not on a corporate giant’s promise of an all-expense paid vacation ... In an egregious violation of the law, Amgen allegedly bribed medical providers and left taxpayers footing the bill for free drug samples.
After watching the FDA advisory meeting for denosumab, I believe Amgen will be lucky to get an osteoporosis indication as a second line treatment for women with a high risk of fractures (the PDUFA date is October 19) ... Amgen was literally pounded by the panel on safety. [Eli Lilly's] Forteo (even thou...
The 2010 Amgen Tour of California will venture high up into the Sierra Nevada Mountains, ...
To win the Amgen Tour of California once, that was huge. To win it twice, that was almost a little bit of a surprise and almost felt like luck ... To have won the Amgen Tour of California three times, it's the sweetest victory of all. It's hard to describe.
To win the Amgen Tour of California once, that was huge. To win it twice, that was almost a little bit of a surprise and almost felt like luck ... To have won the Amgen Tour of California three times, it's the sweetest victory of all. It's hard to describe.
Absolutely! @schwarzenegger, I've decided to ride the #Amgen Tour of California in 2010. Can't wait. What about you @levileipheimer??
Great news for American cycling fans and CA. The 2010 Amgen Tour of California will be better than ever. @lancearmstrong will you join us?
Sacramento is delighted to once again be playing a major role in the Amgen Tour of California
For the 2010 Amgen Tour of California we had the unique opportunity to move our race to a part of the year when we are almost guaranteed great weather in California
Sponsorship of the Amgen Tour of California has given Amgen the opportunity to educate people about the great advances in medicine made possible through biotechnology, and to strengthen our relationships with local communities, cancer support organizations and cancer survivors through our Breakaway from...
Choosing the host cities for the Amgen Tour of California gets more and more difficult every year, as interest in the race continues to grow throughout the state ... We are fortunate to have visited some of the best cities in the state during the last four years and the list keeps growing with the addit...
This world-class cycling race builds on San Jose's rich cycling history and the terrific Amgen Tour of California stages produced by San Jose since 2006. As a city that encourages cycling as an alternative form of transportation, the Tour raises awareness about the environmental and health benefits of c...
San Jose is honored to host the Amgen Tour of California for the fifth year in a row -- every year since the event's inception
2010 Amgen Tour of California - I will be there as national time trial champ
The city of Thousand Oaks is thrilled to play host to the 2010 Amgen Tour of California ... We are delighted to showcase the spectacular landscapes of our Conejo Valley during the final stage of this world-class cycling event.
Now companies like Amgen and Genentech and J & J [Johnson & Johnson] and other companies that you know are doing their logistics work right here from Louisville ... In fact, Genentech, the first investment made outside of the state of California was right here in Louisville and it was right here because...
Amgen is fully committed to working with the FDA to make Prolia available to patients in the near future.
Amgen and Pfizer are committed to ongoing research of ENBREL to grow the overall amount of information available about ENBREL and its safety and efficacy profile.
The Amgen Foundation’s matching grant to VC Together helps us come together with businesses and individuals in the county to assist our neighbors who are struggling to meet basic needs
We’ve dominated domestically this year and we hope to cap the season off by winning the Jayco Herald Sun Tour ... We’ve done races like the Amgen Tour of California this year but this is the largest Australian race we’ll do and we want to showcase what we can do. Based on their form of the past couple o...
Patient Advocate Foundation is proud to renew our partnership with Amgen and Breakaway from Cancer in raising awareness about the variety of resources available to cancer patients, and to participate in The Dempsey Challenge: A Journey for Hope, as we support The Patrick Dempsey Center for Cancer Hope &...
Patient Advocate Foundation thanks Mr. Dempsey for helping raise needed funds for cancer education and wellness services in honor of his mother’s experiences with ovarian cancer, which approximately 20,000 American women are diagnosed with each year, and which remained one of the top 10 cancer diagnosis...
any of those — Wyeth is one of my favorites for that part of the portfolio — in biotechnology, Amgen is an inexpensive stock and, I think, in the heat of health-care reform, the health-care service segment presents an interesting risk-reward. UnitedHealth Group is a way to play that.
Amgen has an established track record of success in oncology and an expanding presence in antibody-based therapeutics
We are pleased with today's decision ... The successful enforcement of intellectual property rights enables Amgen to continue to invest in truly innovative new medicines.
- Tradingchamp
3 days ago
- schaeffers
3 days ago
- nudecycling
5 days ago
- marciomtc
6 days ago
- trygvo
6 days ago
